Page last updated: 2024-09-05

erlotinib hydrochloride and folic acid

erlotinib hydrochloride has been researched along with folic acid in 2 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (folic acid)	Trials (folic acid)	Recent Studies (post-2010) (folic acid)
4,353	786	3,033	30,001	1,945	10,195

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calhau, C; Giovannetti, E; Jansen, G; Kathmann, I; Lemos, C; Peters, GJ	1
Egido, J; Falke, LL; Goldschmeding, R; Mezzano, S; Morgado-Pascual, JL; Ortiz, A; Rayego-Mateos, S; Rodrigues-Diez, R; Rodrigues-Diez, RR; Ruiz-Ortega, M	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and folic acid

Article	Year
Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib. British journal of cancer, 2009, Apr-07, Volume: 100, Issue:7 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Folic Acid; Gefitinib; Genotype; Humans; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines	2009
Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation. The Journal of pathology, 2018, Volume: 244, Issue:2 Topics: Animals; Connective Tissue Growth Factor; Disease Models, Animal; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Fibroblasts; Fibrosis; Folic Acid; G2 Phase Cell Cycle Checkpoints; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NIH 3T3 Cells; Peptide Fragments; Protein Kinase Inhibitors; Receptor, trkA; Signal Transduction; STAT3 Transcription Factor	2018

Article

Year

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib.

British journal of cancer, 2009, Apr-07, Volume: 100, Issue:7

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Folic Acid; Gefitinib; Genotype; Humans; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines

2009

Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.

The Journal of pathology, 2018, Volume: 244, Issue:2

Topics: Animals; Connective Tissue Growth Factor; Disease Models, Animal; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Fibroblasts; Fibrosis; Folic Acid; G2 Phase Cell Cycle Checkpoints; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NIH 3T3 Cells; Peptide Fragments; Protein Kinase Inhibitors; Receptor, trkA; Signal Transduction; STAT3 Transcription Factor

2018